BATCH-2918 · filed
EU Parliament votes on contested hazardous substances cosmetics bill
EU Parliament has voted on controversial legislation targeting hazardous substances in cosmetics, a move that will reshape formulation, safety assessment and labelling pipelines for every brand selling into the bloc.
By Marcus Bennett · · 3 min read · 619 words
Composition
- EU Parliament voted on legislation targeting hazardous substances used in cosmetic products
- Existing EU Cosmetics Regulation (EC) No 1223/2009 already restricts substances via Annexes II and III
- Article 10 of the Cosmetics Regulation governs product information file updates triggered by any concentration threshold change
- REACH already covers workplace and environmental exposure for many substances that would be targeted by the new file
- Non-EU exporters (US, Japanese, Korean manufacturers) would be required to rebuild their EU technical files

The European Union has voted on controversial legislation targeting hazardous substances used in cosmetic products, a move that will reshape formulation, safety assessment and labelling pipelines for any brand selling into the bloc.
The vote, reported by FashionNetwork France, advances a file whose final scope, transitional periods and concentration thresholds are not yet confirmed in the public record. What is already evident from the surrounding industry response is that the dossier has reopened a fault line the cosmetics sector has negotiated before: how far the precautionary principle should extend when safer substitutes are not yet available at industrial scale.
Why "controversial" is the operative word
The legislation arrives in a regulatory environment that already obliges cosmetic manufacturers to exclude a long list of substances under Annexes II and III of Regulation (EC) No 1223/2009 — the so-called Cosmetics Regulation that governs every product placed on the EU market. Any new horizontal restriction aimed at hazardous substances therefore raises immediate questions for formulators:
- Will the new rule operate as an amendment to existing Annexes, or as a stand-alone instrument with its own compliance timeline?
- Does it apply to finished formulations only, or does it extend upstream to raw material suppliers and contract manufacturers?
- What transitional window will brands have to reformulate, requalify and re-notify via the CPNP portal?
Each question carries an operational cost. A stand-alone instrument typically forces a parallel safety dossier; an Annex amendment integrates into existing processes but still demands toxicological review and INCI re-disclosure where concentration limits change.
How heavy is the compliance workload?
For compliance officers, the practical workload starts with mapping the dossier's restricted substances list against the company's existing raw material inventory. That exercise alone can run several weeks for mid-sized brands and several months for groups with portfolios in the hundreds of SKUs. Safety assessors will need updated certificates of analysis from every upstream supplier, and procurement teams will face the familiar scramble to qualify alternative grades of preservatives, UV filters, solvents and fragrance components.
The downstream paperwork is no lighter. Any change to a restricted substance's concentration threshold triggers a product information file update under Article 10 of the Cosmetics Regulation, plus revised labelling where allergen declarations or warning phrases shift. Brands operating outside the EU but exporting into it — a category that includes the bulk of US, Japanese and Korean manufacturers — must rebuild their EU technical files from scratch.
Where do trade federations stand?
Industry federations including Cosmetics Europe have historically pushed back against horizontal chemical restrictions that extend beyond cosmetic-specific risk assessment, arguing that REACH already covers workplace and environmental exposure for many of the same substances. Smaller and indie formulators, meanwhile, tend to welcome clearer thresholds because those thresholds reduce the cost of interpreting ambiguous restrictions — provided they remain workable for short-run production.
What does it mean for treatment menus and procurement?
For salon and spa brands, the file may force a quiet overhaul of professional product lines — peel solutions, keratin treatments, colour systems — that have leaned on specific solvents or resins now under review. Procurement managers should expect supplier price adjustments as reformulated grades enter the market at premium pricing, with availability windows tightening over the next reformulation cycle.
What to watch next
The next data points for the trade are the publication of the voted text, the Council's position and the start of trilogue negotiations. Formulators with active pipelines should already be flagging any substance under the discussion's likely scope for substitution review, even before the formal text drops.
A confirmed publication of the voted text, expected in the coming weeks, will set the reformulation clock for every brand with EU-market SKUs.
via Google News - Cosmetics Regulation (Source)
More from Marcus Bennett
Show full bio
Correspondent covering consumer brands and retail at INCI File.
106 articles
Cross-references · Related articles
- EU Parliament votes on hazardous cosmetics substance bill
- Six beauty ingredients legal in US, banned in EU: the compliance gap that shapes formulation
- New EU Regulation Tightens Rules on Cosmetic Substances
- EU Tightens Chemical and Cosmetics Safety Rules
- Mishcon de Reya flags 2026 UK and EU cosmetics law updates
End of monograph · 3 min read